TY - JOUR

T1 - Adding psychotherapy to antidepressant medication in depression and anxiety disorders

T2 - A meta-analysis

AU - Cuijpers, Pim

AU - Sijbrandij, Marit

AU - Koole, Sander L.

AU - Andersson, Gerhard

AU - Beekman, Aartjan T.

AU - Reynolds, Charles F.

PY - 2014/2

Y1 - 2014/2

N2 - We conducted a meta-analysis of randomized trials in which the effects of treatment with antidepressant medication were compared to the effects of combined pharmacotherapy and psychotherapy in adults with a diagnosed depressive or anxiety disorder. A total of 52 studies (with 3,623 patients) met inclusion criteria, 32 on depressive disorders and 21 on anxiety disorders (one on both depressive and anxiety disorders). The overall difference between pharmacotherapy and combined treatment was Hedges' g = 0.43 (95% CI: 0.31-0.56), indicating a moderately large effect and clinically meaningful difference in favor of combined treatment, which corresponds to a number needed to treat (NNT) of 4.20. There was sufficient evidence that combined treatment is superior for major depression, panic disorder, and obsessive-compulsive disorder (OCD). The effects of combined treatment compared with placebo only were about twice as large as those of pharmacotherapy compared with placebo only, underscoring the clinical advantage of combined treatment. The results also suggest that the effects of pharmacotherapy and those of psychotherapy are largely independent from each other, with both contributing about equally to the effects of combined treatment. We conclude that combined treatment appears to be more effective than treatment with antidepressant medication alone in major depression, panic disorder, and OCD. These effects remain strong and significant up to two years after treatment. Monotherapy with psychotropic medication may not constitute optimal care for common mental disorders.

AB - We conducted a meta-analysis of randomized trials in which the effects of treatment with antidepressant medication were compared to the effects of combined pharmacotherapy and psychotherapy in adults with a diagnosed depressive or anxiety disorder. A total of 52 studies (with 3,623 patients) met inclusion criteria, 32 on depressive disorders and 21 on anxiety disorders (one on both depressive and anxiety disorders). The overall difference between pharmacotherapy and combined treatment was Hedges' g = 0.43 (95% CI: 0.31-0.56), indicating a moderately large effect and clinically meaningful difference in favor of combined treatment, which corresponds to a number needed to treat (NNT) of 4.20. There was sufficient evidence that combined treatment is superior for major depression, panic disorder, and obsessive-compulsive disorder (OCD). The effects of combined treatment compared with placebo only were about twice as large as those of pharmacotherapy compared with placebo only, underscoring the clinical advantage of combined treatment. The results also suggest that the effects of pharmacotherapy and those of psychotherapy are largely independent from each other, with both contributing about equally to the effects of combined treatment. We conclude that combined treatment appears to be more effective than treatment with antidepressant medication alone in major depression, panic disorder, and OCD. These effects remain strong and significant up to two years after treatment. Monotherapy with psychotropic medication may not constitute optimal care for common mental disorders.

KW - Health sciences

KW - antidepressant medication

KW - anxiety disorders

KW - Combined treatment

KW - depressive disorders

KW - dysthymia

KW - meta-analysis

KW - obsessive-compulsive disorder

KW - psychotherapy

UR - http://www.scopus.com/inward/record.url?scp=84893469647&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/62cb50f9-6ecf-36c1-a8e9-44fda4cc6d25/

U2 - 10.1002/wps.20089

DO - 10.1002/wps.20089

M3 - Journal articles

C2 - 24497254

AN - SCOPUS:84893469647

VL - 13

SP - 56

EP - 67

JO - World Psychiatry

JF - World Psychiatry

SN - 1723-8617

IS - 1

ER -